Thompson Davis & Co’s Allergan Inc AGN Stock Holding History

Thompson Davis & Co’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-900	Closed	-$100K	–	936
2013 Q4	$100K	Buy	+900	New	+$86K	0.15%	160

Other funds holding AGN

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Thompson Davis & Co's AGN Position: Q1 2014 in Review

Thompson Davis & Co sold out of Allergan Inc (AGN) in Q1 2014, closing a stake of 900 shares — an estimated $100K sold.

Thompson Davis & Co first reported a position in AGN in Q4 2013 and held it in 1 quarter. The position peaked at $100K in Q4 2013. 733 funds tracked by Wall St. Rank hold AGN as of Q1 2014.

Thompson Davis & Co reported no remaining Allergan Inc position as of Q1 2014 after selling out during the quarter.
Thompson Davis & Co sold 900 Allergan Inc shares in Q1 2014, an estimated $100K.
Thompson Davis & Co first reported a position in Allergan Inc in Q4 2013 and held it in 1 quarter.
Thompson Davis & Co's Allergan Inc position peaked at $100K in Q4 2013.
733 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2014.

Based on Thompson Davis & Co's 13F filing for Q1 2014, filed 9 May 2014.